BE871298A - Complexe lipoproteique normalisant l'efficacite de la vitamine e et des antioxydants de synthese - Google Patents

Complexe lipoproteique normalisant l'efficacite de la vitamine e et des antioxydants de synthese

Info

Publication number
BE871298A
BE871298A BE191150A BE191150A BE871298A BE 871298 A BE871298 A BE 871298A BE 191150 A BE191150 A BE 191150A BE 191150 A BE191150 A BE 191150A BE 871298 A BE871298 A BE 871298A
Authority
BE
Belgium
Prior art keywords
lipoproteic
vitamin
effectiveness
synthetic antioxidants
normalizing
Prior art date
Application number
BE191150A
Other languages
English (en)
Inventor
P J Bugard
M C G A Henry
J J A Jagu
Original Assignee
Bugard Pierre J
Henry Michel C G A
Jagu Jacques J A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bugard Pierre J, Henry Michel C G A, Jagu Jacques J A filed Critical Bugard Pierre J
Publication of BE871298A publication Critical patent/BE871298A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01013—Sterol esterase (3.1.1.13)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01004—Phospholipase A2 (3.1.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE191150A 1978-10-11 1978-10-16 Complexe lipoproteique normalisant l'efficacite de la vitamine e et des antioxydants de synthese BE871298A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7829073A FR2438481A1 (fr) 1978-10-11 1978-10-11 Complexe lipoproteique normalisant l'efficacite de la vitamine e et des antioxydants de synthese

Publications (1)

Publication Number Publication Date
BE871298A true BE871298A (fr) 1979-02-15

Family

ID=9213628

Family Applications (1)

Application Number Title Priority Date Filing Date
BE191150A BE871298A (fr) 1978-10-11 1978-10-16 Complexe lipoproteique normalisant l'efficacite de la vitamine e et des antioxydants de synthese

Country Status (2)

Country Link
BE (1) BE871298A (fr)
FR (1) FR2438481A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198432A (en) * 1988-01-29 1993-03-30 Center For Innovative Technology Method of preventing chlorohydrocarbon toxicity using sterol derivatives

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2614205A2 (fr) * 1978-10-11 1988-10-28 Bugard Pierre Complexe lipoproteique normalisant l'efficacite de la vitamine e et des antioxydants de synthese.
US5041278A (en) * 1985-10-15 1991-08-20 The Liposome Company, Inc. Alpha tocopherol-based vesicles
US4861580A (en) * 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
FR2715070B1 (fr) * 1994-01-18 1996-02-09 Codif International Sa Produit à activité lipolyptique et sa méthode de préparation.
EA000210B1 (ru) * 1996-04-08 1998-12-24 Российский Университет Дружбы Народов Препарат, защищающий печень при вирусном гепатите

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES296810A1 (es) * 1963-08-07 1964-05-01 H C Burns Company Inc Procedimiento de fabricaciën de un preparado para el tratamiento y control de ciertas enfermedades regenerativas metabëlicas

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198432A (en) * 1988-01-29 1993-03-30 Center For Innovative Technology Method of preventing chlorohydrocarbon toxicity using sterol derivatives

Also Published As

Publication number Publication date
FR2438481A1 (fr) 1980-05-09
FR2438481B1 (fr) 1981-05-29

Similar Documents

Publication Publication Date Title
FR2415340B1 (fr) Systeme d'identification personnelle
BE852195A (fr) Matieres alimentaires pour l'homme et pour les animaux
DK32982A (da) Terapeutisk nyttige tetralinderivater
AR240922A1 (es) "procedimiento para preparar acilureidoalquil-bencensulfo-nilureas".
KR880700663A (ko) 망으로 부터 얻은 지질 및 이것을 화장품으로 사용하기 위한 방법
BE871298A (fr) Complexe lipoproteique normalisant l'efficacite de la vitamine e et des antioxydants de synthese
IT1193657B (it) Dispositivo segnalatore dell'usura delle guarnizioni su ganasce di frenatura
IT7967092A0 (it) Composizione di lubrificazione e separazione per fucinatura isotermica
AT382075B (de) Hautpflegemittel
DE3667659D1 (de) Substituierte benzolsulfonamide und antiglaukom-zusammensetzungen die sie enthalten.
IT1193972B (it) Impianto per la rivelazione dell'inviluppo di un segnale
ES508811A0 (es) "prodedimiento para la preparacion de derivados de fenoxi-aminipropanol"
FR2557936B1 (fr) Attache borgne
FR2336945A1 (fr) Composition pour la sterilisation des femmes et des femelles d'animaux
IT7819687A0 (it) Radioanalisi simultanea di folato e vitamina b 12
DE3669497D1 (de) Cycloalkan-1-ol derivate und duftstoff-zusammensetzungen, die diese enthalten.
OA05718A (fr) Mélanges eutectiques d'huiles alimentaires.
TR21851A (tr) Haloasetamidin'ler ve bunlarin herbisid olarak kullanilmasi
IT1172075B (it) Prodotto cosmetico
IT1134573B (it) Dispositivo per l'espulsione di articoli
BE883954A (fr) "spanningsverzorgingsschakeling"
ES512151A0 (es) "procedimiento para preparar derivados de bencilazol."
BE865196A (fr) Complement mineral d'alimentation animale
IT1096093B (it) Impianto per l'applicazione di laminati
ES516464A0 (es) "procedimiento para preparar nuevos derivados organofosfonados".

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BUGARD PIERRE J.

Effective date: 19901031

Owner name: HENRY MICHEL C. G. A.

Effective date: 19901031

Owner name: JAGU JACQUES J. A.

Effective date: 19901031